MX2016017321A - Combinacicones y metodos para el tratamiento de dolor neuropatico. - Google Patents

Combinacicones y metodos para el tratamiento de dolor neuropatico.

Info

Publication number
MX2016017321A
MX2016017321A MX2016017321A MX2016017321A MX2016017321A MX 2016017321 A MX2016017321 A MX 2016017321A MX 2016017321 A MX2016017321 A MX 2016017321A MX 2016017321 A MX2016017321 A MX 2016017321A MX 2016017321 A MX2016017321 A MX 2016017321A
Authority
MX
Mexico
Prior art keywords
neuropathic pain
treatment
combinations
methods
present
Prior art date
Application number
MX2016017321A
Other languages
English (en)
Inventor
Cecilia Bravo Lamicq Elia
Edith Zárate Rodriguez Juana
Original Assignee
Cidat S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cidat S A De C V filed Critical Cidat S A De C V
Publication of MX2016017321A publication Critical patent/MX2016017321A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presenta invención se relaciona con un método de tratamiento de dolor neuropático, que comprende co-administrar ácido alfa lipoico y pregabalina. La presente invención también proporciona una composición farmacéutica que comprende una combinación de ácido alfa lipoico y pregabalina. La composición farmacéutica de la presente invención es útil para el tratamiento de dolor neuropático.
MX2016017321A 2016-12-14 2016-12-14 Combinacicones y metodos para el tratamiento de dolor neuropatico. MX2016017321A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2016/000137 WO2018111060A1 (es) 2016-12-14 2016-12-14 Combinaciones y métodos para el tratamiento de dolor neuropático

Publications (1)

Publication Number Publication Date
MX2016017321A true MX2016017321A (es) 2018-08-20

Family

ID=62559579

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016017321A MX2016017321A (es) 2016-12-14 2016-12-14 Combinacicones y metodos para el tratamiento de dolor neuropatico.

Country Status (6)

Country Link
US (1) US20200101043A1 (es)
EP (1) EP3593795A4 (es)
BR (1) BR112019012226A2 (es)
CA (1) CA3047077C (es)
MX (1) MX2016017321A (es)
WO (1) WO2018111060A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102374820B1 (ko) * 2020-11-04 2022-03-16 전남대학교병원 프레가발린 및 티아넵틴을 포함하는 신경병성 통증 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20072051A1 (it) * 2007-10-23 2009-04-24 Chimico Internaz S P A In Brev Composizione a base di pellet di acido lipoico
WO2014168228A1 (ja) * 2013-04-12 2014-10-16 マルホ株式会社 局所用組成物
US20160058752A1 (en) * 2014-02-04 2016-03-03 Afgin Pharma, Llc Topical peripheral neuro-affective (tpna) therapy for neuropathic conditions

Also Published As

Publication number Publication date
BR112019012226A2 (pt) 2019-11-05
WO2018111060A1 (es) 2018-06-21
US20200101043A1 (en) 2020-04-02
CA3047077A1 (en) 2018-06-21
CA3047077C (en) 2024-01-02
EP3593795A4 (en) 2020-05-06
EP3593795A1 (en) 2020-01-15

Similar Documents

Publication Publication Date Title
PH12018501378A1 (en) Compositions and methods for the treatment of hemoglobinopathies
MX2018002962A (es) Compuestos para el tratamiento de enfermedades relacionadas con la produccion de especies de oxigeno reactivo (eor) mitocondrial.
MX2021006734A (es) Metodo para tratar el cancer.
CR20160582A (es) Composición para tratar diabetes, que contienen un conjugado de análogo de insulina de acción prolongada y un conjugado de péptido insulinotrópico de acción prolongada
EA201790764A1 (ru) Новые соединения карбоновых кислот, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1
PH12016501600A1 (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
TN2018000005A1 (en) Agents, uses and methods for the treatment of synucleinopathy
MX2020001757A (es) Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades.
EA201792496A1 (ru) Способы лечения воспаления или нейропатической боли
MX2020005567A (es) Metodos de tratamiento con asparaginasa.
MX2018002344A (es) Metodo para tratar el cancer.
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2019002190A (es) Uso de pridopidina para tratar distonías.
EA201890884A1 (ru) Способ и композиции для нежелательных и аномальных мышечных сокращений
PL3342869T3 (pl) Mikroorganizm z rodzaju Corynebacterium do wytwarzania L-aminokwasu i sposób wytwarzania L-aminokwasu przy jego zastosowaniu
MX2017010654A (es) Oxabicicloheptanos y oxabicicloheptenos para el tratamiento de trastornos depresivos y de estres.
EA201890419A1 (ru) ОТСЕЛЕКТИРОВАННЫЙ АМИД γ-ГИДРОКСИМАСЛЯНОЙ КИСЛОТЫ И ЕГО ПРИМЕНЕНИЯ ПРИ ЛЕЧЕНИИ ЗЛОУПОТРЕБЛЕНИЯ АЛКОГОЛЕМ
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
WO2015075062A3 (en) Method of treating hair
BR112018005602A2 (pt) composição para tratar dor
MX2016017321A (es) Combinacicones y metodos para el tratamiento de dolor neuropatico.
MX2017013601A (es) Un proceso de etapas multiples para la produccion de no.
EA201692538A1 (ru) Экстракт расторопши пятнистой из кожуры плодов расторопши пятнистой, способы его получения и применения
MX2019007490A (es) Composicion que contiene acido n-acetildiamino butirico.